Physician profile
Eric Fisher
NPI 1619925534
$480.96
in general payments reported to CMS, 2019-2025
11 companies · $49.82 in 2025
The $49.82 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $89.21 · 2023: $149 · 2024: $59.40 · 2025: $49.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218 · Consulting Fee: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.05 |
| Consulting Fee | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $120.14 | 2021 | |
| Pfizer INC. | $71.26 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.16 | 2021-2022 | |
| Novo Nordisk INC | $49.82 | 2025 | Wegovy |
| Boston Scientific Corporation | $45.60 | 2024 | Watchman Access System |
| Biomerieux INC | $40.00 | 2023 | Biofire Respiratory Panel 2.1 |
| Novartis Pharmaceuticals Corporation | $27.94 | 2022 | |
| Abbott Laboratories | $23.50 | 2023 | Mitraclip |
| Amgen INC. | $21.08 | 2023 | Evenity, Prolia |
| Astellas Pharma US INC | $16.66 | 2023 | Myrbetriq |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.80 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Fisher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.